MARKET

IBIO

IBIO

IBIO
AMEX

Real-time Quotes | Nasdaq Last Sale

4.565
+0.125
+2.82%
Opening 14:23 08/03 EDT
OPEN
4.585
PREV CLOSE
4.440
HIGH
4.730
LOW
4.430
VOLUME
7.85M
TURNOVER
--
52 WEEK HIGH
7.45
52 WEEK LOW
0.0500
MARKET CAP
639.66M
P/E (TTM)
-3.8588
1D
5D
1M
3M
1Y
5Y

EPS

IBIO News

More
Cramer's lightning round: We like Dynatrace
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 3d ago
NAK, STM among premarket losers
Seeking Alpha - Article · 6d ago
HAS, IBN among premarket losers
Seeking Alpha - Article · 07/27 12:20
INTC, NIO among premarket losers
Seeking Alpha - Article · 07/24 12:24
iBio shares are trading higher despite no company specific news. The stock has traded in almost a 40% range this week.
Benzinga · 07/23 13:19
IBIO, TNXP among premarket gainers
Seeking Alpha - Article · 07/23 12:25
SNAP, FE among premarket losers
Seeking Alpha - Article · 07/22 12:13
iBio shares are continuing higher after the stock rose almost 75% Monday on no apparent news.UPDATE: Shares have since reversed, now lower.
Benzinga · 07/21 14:53

Industry

Pharmaceuticals
+1.39%
Pharmaceuticals & Medical Research
+1.91%

Hot Stocks

Symbol
Price
%Change

About IBIO

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
More

Webull offers kinds of Ibio Inc stock information, including AMEX:IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.